Literature DB >> 11873923

The deferiprone controversy: time to move on.

C David Naylor1.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Hospital for Sick Children (Toronto)

Mesh:

Substances:

Year:  2002        PMID: 11873923      PMCID: PMC99355     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  1 in total

1.  Early Toronto experience with new standards for industry-sponsored clinical research: a progress report.

Authors:  C David Naylor
Journal:  CMAJ       Date:  2002-02-19       Impact factor: 8.262

  1 in total
  5 in total

1.  I beg to differ.

Authors:  Nancy Olivieri
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

2.  Independent inquiry.

Authors:  Patricia Baird; Jon Thompson; Jocelyn Downie
Journal:  CMAJ       Date:  2002-07-09       Impact factor: 8.262

Review 3.  Clinical research: a tale of two studies.

Authors:  David G Nathan
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

4.  Better governance in academic health sciences centres: moving beyond the Olivieri/Apotex Affair in Toronto.

Authors:  L E Ferris; P A Singer; C D Naylor
Journal:  J Med Ethics       Date:  2004-02       Impact factor: 2.903

5.  Freedom of Science - Can Industry Influence What Scientists Publish?

Authors:  Ralph Ziegler; Oliver Schnell; Bernd Kulzer; James Gilbart; Lutz Heinemann
Journal:  Eur Endocrinol       Date:  2014-02-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.